Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Identification of Ideal Allele Combinations for the Adaptation of Spring Barley to Northern Latitudes.

Göransson M, Hallsson JH, Lillemo M, Orabi J, Backes G, Jahoor A, Hermannsson J, Christerson T, Tuvesson S, Gertsson B, Reitan L, Alsheikh M, Aikasalo R, Isolahti M, Veteläinen M, Jalli M, Krusell L, Hjortshøj RL, Eriksen B, Bengtsson T.

Front Plant Sci. 2019 May 3;10:542. doi: 10.3389/fpls.2019.00542. eCollection 2019.

2.

Coronary CT Angiographic and Flow Reserve-Guided Management of Patients With Stable Ischemic Heart Disease.

Nørgaard BL, Terkelsen CJ, Mathiassen ON, Grove EL, Bøtker HE, Parner E, Leipsic J, Steffensen FH, Riis AH, Pedersen K, Christiansen EH, Mæng M, Krusell LR, Kristensen SD, Eftekhari A, Jakobsen L, Jensen JM.

J Am Coll Cardiol. 2018 Oct 30;72(18):2123-2134. doi: 10.1016/j.jacc.2018.07.043. Epub 2018 Aug 25.

3.

Evaluation of Coronary Artery Stenosis by Quantitative Flow Ratio During Invasive Coronary Angiography: The WIFI II Study (Wire-Free Functional Imaging II).

Westra J, Tu S, Winther S, Nissen L, Vestergaard MB, Andersen BK, Holck EN, Fox Maule C, Johansen JK, Andreasen LN, Simonsen JK, Zhang Y, Kristensen SD, Maeng M, Kaltoft A, Terkelsen CJ, Krusell LR, Jakobsen L, Reiber JHC, Lassen JF, Bøttcher M, Bøtker HE, Christiansen EH, Holm NR.

Circ Cardiovasc Imaging. 2018 Mar;11(3):e007107. doi: 10.1161/CIRCIMAGING.117.007107.

4.

Aortic valve and left ventricular outflow tract calcium volume and distribution in transcatheter aortic valve replacement: Influence on the risk of significant paravalvular regurgitation.

Hansson NC, Leipsic J, Pugliese F, Andersen HR, Rossi A, Simonato M, Jensen KT, Christiansen EH, Terkelsen CJ, Blanke P, Tang M, Krusell LR, Klaaborg KE, Terp K, Kennon S, Dvir D, Bøtker HE, Webb J, Nørgaard BL.

J Cardiovasc Comput Tomogr. 2018 Jul - Aug;12(4):290-297. doi: 10.1016/j.jcct.2018.02.002. Epub 2018 Feb 15.

PMID:
29519754
5.

A Novel QTL for Powdery Mildew Resistance in Nordic Spring Barley (Hordeum vulgare L. ssp. vulgare) Revealed by Genome-Wide Association Study.

Bengtsson T, Åhman I, Manninen O, Reitan L, Christerson T, Due Jensen J, Krusell L, Jahoor A, Orabi J.

Front Plant Sci. 2017 Nov 14;8:1954. doi: 10.3389/fpls.2017.01954. eCollection 2017.

6.

Myocardial Perfusion Imaging Versus Computed Tomography Angiography-Derived Fractional Flow Reserve Testing in Stable Patients With Intermediate-Range Coronary Lesions: Influence on Downstream Diagnostic Workflows and Invasive Angiography Findings.

Nørgaard BL, Gormsen LC, Bøtker HE, Parner E, Nielsen LH, Mathiassen ON, Grove EL, Øvrehus KA, Gaur S, Leipsic J, Pedersen K, Terkelsen CJ, Christiansen EH, Kaltoft A, Mæng M, Kristensen SD, Krusell LR, Lassen JF, Jensen JM.

J Am Heart Assoc. 2017 Aug 22;6(8). pii: e005587. doi: 10.1161/JAHA.117.005587.

7.

High-pressure balloon fracturing of small dysfunctional Mitroflow bioprostheses facilitates transcatheter aortic valve-in-valve implantation.

Nielsen-Kudsk JE, Andersen A, Therkelsen CJ, Christensen EH, Jensen KT, Krusell LR, Tang M, Terp KA, Klaaborg KE, Greisen JR, Nørgaard BL, Andersen HR.

EuroIntervention. 2017 Oct 13;13(9):e1020-e1025. doi: 10.4244/EIJ-D-17-00244.

8.

Computed tomography derived fractional flow reserve testing in stable patients with typical angina pectoris: influence on downstream rate of invasive coronary angiography.

Jensen JM, Bøtker HE, Mathiassen ON, Grove EL, Øvrehus KA, Pedersen KB, Terkelsen CJ, Christiansen EH, Maeng M, Leipsic J, Kaltoft A, Jakobsen L, Sørensen JT, Thim T, Kristensen SD, Krusell LR, Nørgaard BL.

Eur Heart J Cardiovasc Imaging. 2018 Apr 1;19(4):405-414. doi: 10.1093/ehjci/jex068.

9.

Randomized comparison of sirolimus eluting, and biolimus eluting bioresorbable polymer stents: the SORT-OUT VII optical coherence tomography study.

Andreasen LN, Holm NR, Balleby IR, Krusell LR, Maeng M, Jakobsen L, Veien KT, Hansen KN, Kristensen SD, Hjort J, Kaltoft A, Dijkstra J, Terkelsen CJ, Lassen JF, Madsen M, Bøtker HE, Jensen LO, Christiansen EH.

Eur Heart J Cardiovasc Imaging. 2018 Mar 1;19(3):329-338. doi: 10.1093/ehjci/jex035.

PMID:
28369332
10.

Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial.

Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Clemmensen P, Holmvang L, Jørgensen E, Pedersen F, Saunamaki K, Ravkilde J, Tilsted HH, Villadsen A, Aarøe J, Jensen SE, Raungaard B, Bøtker HE, Terkelsen CJ, Maeng M, Kaltoft A, Krusell LR, Jensen LO, Veien KT, Kofoed KF, Torp-Pedersen C, Kyhl K, Nepper-Christensen L, Treiman M, Vejlstrup N, Ahtarovski K, Lønborg J, Køber L; Third Danish Study of Optimal Acute Treatment of Patients With ST Elevation Myocardial Infarction–Ischemic Postconditioning (DANAMI-3–iPOST) Investigators.

JAMA Cardiol. 2017 May 1;2(5):490-497. doi: 10.1001/jamacardio.2017.0022.

11.

Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial.

Raungaard B, Christiansen EH, Bøtker HE, Hansen HS, Ravkilde J, Thuesen L, Aarøe J, Villadsen AB, Terkelsen CJ, Krusell LR, Maeng M, Kristensen SD, Veien KT, Hansen KN, Junker A, Madsen M, Andersen SL, Jensen SE, Jensen LO; SORT OUT VI Investigators.

JACC Cardiovasc Interv. 2017 Feb 13;10(3):255-264. doi: 10.1016/j.jcin.2016.11.007. Epub 2017 Jan 18.

12.

Transcatheter Aortic Valve Thrombosis: Incidence, Predisposing Factors, and Clinical Implications.

Hansson NC, Grove EL, Andersen HR, Leipsic J, Mathiassen ON, Jensen JM, Jensen KT, Blanke P, Leetmaa T, Tang M, Krusell LR, Klaaborg KE, Christiansen EH, Terp K, Terkelsen CJ, Poulsen SH, Webb J, Bøtker HE, Nørgaard BL.

J Am Coll Cardiol. 2016 Nov 8;68(19):2059-2069. doi: 10.1016/j.jacc.2016.08.010. Epub 2016 Aug 28.

13.

Utility of Impella® left ventricular assist device during cardiac arrest: A case report.

Støttrup NB, Jakobsen L, Krusell LR, Terkelsen CJ.

Int J Cardiol. 2016 Dec 15;225:111-112. doi: 10.1016/j.ijcard.2016.09.074. Epub 2016 Sep 22. No abstract available.

PMID:
27718442
14.

Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial.

Jensen LO, Thayssen P, Maeng M, Ravkilde J, Krusell LR, Raungaard B, Junker A, Terkelsen CJ, Veien KT, Villadsen AB, Kaltoft A, Tilsted HH, Hansen KN, Aaroe J, Kristensen SD, Hansen HS, Jensen SE, Madsen M, Bøtker HE, Berencsi K, Lassen JF, Christiansen EH.

Circ Cardiovasc Interv. 2016 Jul;9(7). pii: e003610. doi: 10.1161/CIRCINTERVENTIONS.115.003610.

PMID:
27412869
15.

Staged re-evaluation of non-culprit lesions in ST segment elevation myocardial infarction: a retrospective study.

Thim T, Egholm G, Olesen KK, Kaltoft A, Terkelsen CJ, Krusell LR, Kristensen SD, Bøtker HE, Christiansen EH, Maeng M.

Open Heart. 2016 Jun 24;3(1):e000427. doi: 10.1136/openhrt-2016-000427. eCollection 2016.

16.

Clinical Use of Coronary CTA-Derived FFR for Decision-Making in Stable CAD.

Nørgaard BL, Hjort J, Gaur S, Hansson N, Bøtker HE, Leipsic J, Mathiassen ON, Grove EL, Pedersen K, Christiansen EH, Kaltoft A, Gormsen LC, Mæng M, Terkelsen CJ, Kristensen SD, Krusell LR, Jensen JM.

JACC Cardiovasc Imaging. 2017 May;10(5):541-550. doi: 10.1016/j.jcmg.2015.11.025. Epub 2016 Apr 13.

17.

Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IV.

Jensen LO, Thayssen P, Christiansen EH, Maeng M, Ravkilde J, Hansen KN, Hansen HS, Krusell L, Kaltoft A, Tilsted HH, Berencsi K, Junker A, Lassen JF; SORT OUT IV Investigators.

J Am Coll Cardiol. 2016 Feb 23;67(7):751-62. doi: 10.1016/j.jacc.2015.11.051.

18.

Fracturing the Ring of Small Mitroflow Bioprostheses by High-Pressure Balloon Predilatation in Transcatheter Aortic Valve-in-Valve Implantation.

Nielsen-Kudsk JE, Christiansen EH, Terkelsen CJ, Nørgaard BL, Jensen KT, Krusell LR, Tang M, Terp K, Klaaborg KE, Andersen HR.

Circ Cardiovasc Interv. 2015 Aug;8(8):e002667. doi: 10.1161/CIRCINTERVENTIONS.115.002667. No abstract available.

PMID:
26208503
19.

Receptor-mediated exopolysaccharide perception controls bacterial infection.

Kawaharada Y, Kelly S, Nielsen MW, Hjuler CT, Gysel K, Muszyński A, Carlson RW, Thygesen MB, Sandal N, Asmussen MH, Vinther M, Andersen SU, Krusell L, Thirup S, Jensen KJ, Ronson CW, Blaise M, Radutoiu S, Stougaard J.

Nature. 2015 Jul 16;523(7560):308-12. doi: 10.1038/nature14611. Epub 2015 Jul 8.

PMID:
26153863
20.

A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).

Maeng M, Baranauskas A, Christiansen EH, Kaltoft A, Holm NR, Krusell LR, Ravkilde J, Tilsted HH, Thayssen P, Jensen LO.

Catheter Cardiovasc Interv. 2015 Dec 1;86(7):1161-7. doi: 10.1002/ccd.25875. Epub 2015 May 6.

PMID:
25640050
21.

Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial.

Raungaard B, Jensen LO, Tilsted HH, Christiansen EH, Maeng M, Terkelsen CJ, Krusell LR, Kaltoft A, Kristensen SD, Bøtker HE, Thuesen L, Aarøe J, Jensen SE, Villadsen AB, Thayssen P, Veien KT, Hansen KN, Junker A, Madsen M, Ravkilde J, Lassen JF; Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT).

Lancet. 2015 Apr 18;385(9977):1527-35. doi: 10.1016/S0140-6736(14)61794-3. Epub 2015 Jan 16. Erratum in: Lancet. 2015 Apr 18;385(9977):1510.

PMID:
25601789
22.

Co-registration of optical coherence tomography and X-ray angiography in percutaneous coronary intervention. the Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) fusion study.

Hebsgaard L, Nielsen TM, Tu S, Krusell LR, Maeng M, Veien KT, Raungaard B, Terkelsen CJ, Kaltoft A, Reiber JH, Lassen JF, Christiansen EH, Holm NR.

Int J Cardiol. 2015 Mar 1;182:272-8. doi: 10.1016/j.ijcard.2014.12.088. Epub 2014 Dec 27.

23.

Separate norovirus outbreaks linked to one source of imported frozen raspberries by molecular analysis, Denmark, 2010-2011.

Müller L, Schultz AC, Fonager J, Jensen T, Lisby M, Hindsdal K, Krusell L, Eshøj A, Møller LT, Porsbo LJ, Böttiger BE, Kuhn K, Engberg J, Ethelberg S.

Epidemiol Infect. 2015 Aug;143(11):2299-307. doi: 10.1017/S0950268814003409. Epub 2014 Dec 22.

PMID:
25530074
24.

Long-term outcome of sirolimus-eluting and zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a Danish organization for randomized trials on clinical outcome III substudy).

Olesen KK, Tilsted HH, Jensen LO, Kaltoft A, Krusell LR, Ravkilde J, Christiansen EH, Madsen M, Thayssen P, Sørensen HT, Lassen JF, Maeng M.

Am J Cardiol. 2015 Feb 1;115(3):298-302. doi: 10.1016/j.amjcard.2014.10.038. Epub 2014 Nov 11.

PMID:
25499925
25.

Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study.

Thim T, Johansen MB, Chisholm GE, Schmidt M, Kaltoft A, Sørensen HT, Thuesen L, Kristensen SD, Bøtker HE, Krusell LR, Lassen JF, Thayssen P, Jensen LO, Tilsted HH, Maeng M.

BMC Cardiovasc Disord. 2014 Aug 13;14:100. doi: 10.1186/1471-2261-14-100.

26.

Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.

Maeng M, Tilsted HH, Jensen LO, Krusell LR, Kaltoft A, Kelbæk H, Villadsen AB, Ravkilde J, Hansen KN, Christiansen EH, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Thuesen L, Madsen M, Thayssen P, Sørensen HT, Lassen JF.

Lancet. 2014 Jun 14;383(9934):2047-2056. doi: 10.1016/S0140-6736(14)60405-0. Epub 2014 Mar 14.

PMID:
24631162
27.

Randomised comparison of manual compression and FemoSeal™ vascular closure device for closure after femoral artery access coronary angiography: the CLOSure dEvices Used in everyday Practice (CLOSE-UP) study.

Holm NR, Sindberg B, Schou M, Maeng M, Kaltoft A, Bøttcher M, Krusell LR, Hjort J, Thuesen L, Terkelsen CJ, Christiansen EH, Bøtker HE, Kristensen SD, Lassen JF; CLOSE-UP study group.

EuroIntervention. 2014 Jun;10(2):183-90. doi: 10.4244/EIJV10I2A31.

28.

Feasibility and early safety of hybrid coronary revascularisation combining off-pump coronary surgery through J-hemisternotomy with percutaneous coronary intervention.

Modrau IS, Nielsen PH, Bøtker HE, Christiansen EH, Krusell LR, Kaltoft AK, Mæng M, Terkelsen CJ, Kristensen SD, Lassen JF, Thuesen L.

EuroIntervention. 2015 Feb;10(10):e1-6. doi: 10.4244/EIJV10I10A195.

29.

Three-dimensional multidetector computed tomography versus conventional 2-dimensional transesophageal echocardiography for annular sizing in transcatheter aortic valve replacement: Influence on postprocedural paravalvular aortic regurgitation.

Hansson NC, Thuesen L, Hjortdal VE, Leipsic J, Andersen HR, Poulsen SH, Webb JG, Christiansen EH, Rasmussen LE, Krusell LR, Terp K, Klaaborg KE, Tang M, Lassen JF, Bøtker HE, Nørgaard BL.

Catheter Cardiovasc Interv. 2013 Nov 15;82(6):977-86. doi: 10.1002/ccd.25005. Epub 2013 Jul 19.

PMID:
23703899
30.

Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).

Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.

JACC Cardiovasc Interv. 2013 Jun;6(6):548-53. doi: 10.1016/j.jcin.2012.12.129. Epub 2013 May 15.

31.

Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.

Christiansen EH, Jensen LO, Thayssen P, Tilsted HH, Krusell LR, Hansen KN, Kaltoft A, Maeng M, Kristensen SD, Bøtker HE, Terkelsen CJ, Villadsen AB, Ravkilde J, Aarøe J, Madsen M, Thuesen L, Lassen JF; Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT) V investigators.

Lancet. 2013 Feb 23;381(9867):661-9. doi: 10.1016/S0140-6736(12)61962-X. Epub 2013 Jan 30. Erratum in: Lancet. 2013 Jul 27;382(9889):310. Noergaard, Bjarne Linde [corrected to Norgaard, Bjarne Linde].

PMID:
23374649
32.

The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation.

Thayssen P, Jensen LO, Lassen JF, Tilsted HH, Kaltoft A, Christiansen EH, Hansen KN, Ravkilde J, Maeng M, Krusell L, Madsen M, Sørensen HT, Thuesen L; Western Denmark Heart Registry.

EuroIntervention. 2012 Sep;8(5):591-8. doi: 10.4244/EIJV8I5A91.

33.

2-year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial.

Jensen LO, Thayssen P, Christiansen EH, Tilsted HH, Maeng M, Hansen KN, Kaltoft A, Hansen HS, Bøtker HE, Krusell LR, Ravkilde J, Madsen M, Thuesen L, Lassen JF; SORT OUT IV Investigators.

J Am Coll Cardiol. 2012 Sep 25;60(13):1140-7. doi: 10.1016/j.jacc.2012.07.004. Epub 2012 Sep 5.

34.

3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents.

Maeng M, Tilsted HH, Jensen LO, Kaltoft A, Kelbæk H, Abildgaard U, Villadsen AB, Krusell LR, Ravkilde J, Hansen KN, Christiansen EH, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Madsen M, Thayssen P, Sørensen HT, Thuesen L, Lassen JF.

JACC Cardiovasc Interv. 2012 Aug;5(8):812-8. doi: 10.1016/j.jcin.2012.04.008.

35.

Legume receptors perceive the rhizobial lipochitin oligosaccharide signal molecules by direct binding.

Broghammer A, Krusell L, Blaise M, Sauer J, Sullivan JT, Maolanon N, Vinther M, Lorentzen A, Madsen EB, Jensen KJ, Roepstorff P, Thirup S, Ronson CW, Thygesen MB, Stougaard J.

Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13859-64. doi: 10.1073/pnas.1205171109. Epub 2012 Aug 2.

36.

A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial.

Nielsen HH, Klaaborg KE, Nissen H, Terp K, Mortensen PE, Kjeldsen BJ, Jakobsen CJ, Andersen HR, Egeblad H, Krusell LR, Thuesen L, Hjortdal VE.

EuroIntervention. 2012 Jul 20;8(3):383-9. doi: 10.4244/EIJV8I3A58.

37.

Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV).

Jensen LO, Thayssen P, Hansen HS, Christiansen EH, Tilsted HH, Krusell LR, Villadsen AB, Junker A, Hansen KN, Kaltoft A, Maeng M, Pedersen KE, Kristensen SD, Bøtker HE, Ravkilde J, Sanchez R, Aarøe J, Madsen M, Sørensen HT, Thuesen L, Lassen JF; Scandinavian Organization for Randomized Trials With Clinical Outcome IV (SORT OUT IV) Investigators.

Circulation. 2012 Mar 13;125(10):1246-55. doi: 10.1161/CIRCULATIONAHA.111.063644. Epub 2012 Feb 3. Erratum in: Circulation. 2013 Sep 3;128(10):e158. Noergaard, Bjarne Linde [corrected to Norgaard, Bjarne Linde].

PMID:
22308301
38.

Influence of pre-infarction angina, collateral flow, and pre-procedural TIMI flow on myocardial salvage index by cardiac magnetic resonance in patients with ST-segment elevation myocardial infarction.

Lønborg J, Kelbæk H, Vejlstrup N, Bøtker HE, Kim WY, Holmvang L, Jørgensen E, Helqvist S, Saunamäki K, Thuesen L, Krusell LR, Clemmensen P, Engstrøm T.

Eur Heart J Cardiovasc Imaging. 2012 May;13(5):433-43. doi: 10.1093/ejechocard/jer296. Epub 2011 Dec 29.

PMID:
22207343
39.

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.

Lønborg J, Vejlstrup N, Kelbæk H, Bøtker HE, Kim WY, Mathiasen AB, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Thuesen L, Krusell LR, Jensen JS, Køber L, Treiman M, Holst JJ, Engstrøm T.

Eur Heart J. 2012 Jun;33(12):1491-9. doi: 10.1093/eurheartj/ehr309. Epub 2011 Sep 14.

PMID:
21920963
40.

Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III Substudy).

Maeng M, Jensen LO, Tilsted HH, Kaltoft A, Kelbaek H, Abildgaard U, Villadsen A, Aarøe J, Thayssen P, Krusell LR, Christiansen EH, Bøtker HE, Kristensen SD, Ravkilde J, Madsen M, Sørensen HT, Rasmussen K, Thuesen L, Lassen JF.

Am J Cardiol. 2011 Nov 1;108(9):1232-7. doi: 10.1016/j.amjcard.2011.06.037. Epub 2011 Aug 23.

PMID:
21864817
41.

System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial).

Nielsen PH, Terkelsen CJ, Nielsen TT, Thuesen L, Krusell LR, Thayssen P, Kelbaek H, Abildgaard U, Villadsen AB, Andersen HR, Maeng M; Danami-2 Investigators.

Am J Cardiol. 2011 Sep 15;108(6):776-81. doi: 10.1016/j.amjcard.2011.05.007. Epub 2011 Jul 15.

PMID:
21757183
42.

Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial.

Jensen LO, Maeng M, Thayssen P, Villadsen A, Krusell L, Botker HE, Pedersen KE, Aaroe J, Christiansen EH, Vesterlund T, Hansen KN, Ravkilde J, Tilsted HH, Lassen JF, Thuesen L.

EuroIntervention. 2011 Jul;7(3):323-31. doi: 10.4244/EIJV7I3A56.

43.

The Clavata2 genes of pea and Lotus japonicus affect autoregulation of nodulation.

Krusell L, Sato N, Fukuhara I, Koch BE, Grossmann C, Okamoto S, Oka-Kira E, Otsubo Y, Aubert G, Nakagawa T, Sato S, Tabata S, Duc G, Parniske M, Wang TL, Kawaguchi M, Stougaard J.

Plant J. 2011 Mar;65(6):861-71. doi: 10.1111/j.1365-313X.2010.04474.x. Epub 2011 Jan 31.

44.

Autophosphorylation is essential for the in vivo function of the Lotus japonicus Nod factor receptor 1 and receptor-mediated signalling in cooperation with Nod factor receptor 5.

Madsen EB, Antolín-Llovera M, Grossmann C, Ye J, Vieweg S, Broghammer A, Krusell L, Radutoiu S, Jensen ON, Stougaard J, Parniske M.

Plant J. 2011 Feb;65(3):404-17. doi: 10.1111/j.1365-313X.2010.04431.x. Epub 2010 Dec 15.

45.

Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial.

Kaltoft A, Kelbaek H, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.

J Am Coll Cardiol. 2010 Aug 17;56(8):641-5. doi: 10.1016/j.jacc.2010.05.009.

46.

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.

Rasmussen K, Maeng M, Kaltoft A, Thayssen P, Kelbaek H, Tilsted HH, Abildgaard U, Christiansen EH, Engstrøm T, Krusell LR, Ravkilde J, Hansen PR, Hansen KN, Abildstrøm SZ, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Madsen M, Johnsen SP, Jensen LO, Sørensen HT, Thuesen L, Lassen JF; SORT OUT III study group.

Lancet. 2010 Mar 27;375(9720):1090-9. doi: 10.1016/S0140-6736(10)60208-5. Epub 2010 Mar 16.

PMID:
20231034
47.

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial.

Bøtker HE, Kharbanda R, Schmidt MR, Bøttcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sørensen HT, Redington AN, Nielsen TT.

Lancet. 2010 Feb 27;375(9716):727-34. doi: 10.1016/S0140-6736(09)62001-8.

PMID:
20189026
48.

Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.

Jensen LO, Maeng M, Thayssen P, Kaltoft A, Tilsted HH, Bøttcher M, Lassen JF, Hansen KN, Krusell LR, Rasmussen K, Pedersen KE, Pedersen L, Paaske Johnsen S, Sørensen HT, Thuesen L.

Circ Cardiovasc Interv. 2008 Dec;1(3):176-84. doi: 10.1161/CIRCINTERVENTIONS.108.794578.

PMID:
20031676
49.

A novel GGA-binding site is required for intracellular sorting mediated by stabilin-1.

Zhang J, Gratchev A, Riabov V, Mamidi S, Schmuttermaier C, Krusell L, Kremmer E, Workman G, Sage EH, Jalkanen S, Goerdt S, Kzhyshkowska J.

Mol Cell Biol. 2009 Nov;29(22):6097-105. doi: 10.1128/MCB.00505-09. Epub 2009 Sep 14.

50.

Sirolimus-eluting versus bare-metal stent implantation in patients with ostial lesions.

Jørgensen E, Kelbæk H, Kløvgaard L, Thuesen L, Krusell LR, Bøtker HE, Saunamäki K, Lassen JF, Helqvist S.

Int J Cardiol. 2010 Nov 5;145(1):162-3. doi: 10.1016/j.ijcard.2009.07.043. Epub 2009 Aug 28.

PMID:
19716192

Supplemental Content

Loading ...
Support Center